← All companies

Strand Therapeutics

Healthcare & Life Sci

Company overview

Strand Therapeutics is a clinical-stage biotechnology company. It develops mRNA-based treatments for cancers and autoimmune diseases. Its work is built on technology platforms called SignalPath LNPs, SignalLock RNA, and SignalScript RNA. In August 2025, the company raised $153 million in Series B financing. Strand Therapeutics is an H-1B sponsor.

Industry
Healthcare & Life Sci
Headquarters
United States

Filters

Create your account

Create an account to save jobs and track applications.